Go to content
UR Home

All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma

URN to cite this document:
DOI to cite this document:
Heudobler, Daniel ; Fante, Matthias A. ; Felsensteiner, Mona ; Mayer, Stephanie ; Gerken, Michael ; Klinkhammer-Schalke, Monika ; Herr, Wolfgang ; Vogelhuber, Martin ; Reichle, Albrecht
License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 28 Apr 2022 10:45


PurposeTreatment options in patients (pts.) with advanced relapsed and refractory aggressive B-cell lymphoma are limited. Palliative all-oral chemotherapy regimens reduce in-patient visits and contribute to quality of life. The all-oral low-dose chemotherapy regimen TEPIP comprises the conventional chemotherapy agents trofosfamide, etoposide, procarbazine, idarubicin and prednisolone. ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons